StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.32−0.33 (-0.64%)

Close on Nov 18, 2026Market cap $7.13BP/E –Yield –

Cytokinetics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cytokinetics's pe ratio was 702.5× on Jul 31, 2017, against 6.5× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2017Jul 31, 2017702.5×+698.0
2011Jan 31, 20114.5×−0.5
2010Dec 31, 20105.0×–

More Cytokinetics figures

See a number that looks wrong?